Elevated DHEA-S Levels May Shorten Lifespan in Men, No Impact Observed in Women
New genetic research links higher DHEA-S hormone levels to shorter lifespan in men, highlighting gender-specific health effects and raising questions about supplement regulation.
Recent research indicates a significant link between higher levels of the hormone dehydroepiandrosterone sulfate (DHEA-S) and reduced lifespan in men. The study, led by Professor Mary Schooling from CUNY School of Public Health, employed a Mendelian randomization approach, analyzing genetic data from large European cohorts to determine causal relationships while minimizing confounding factors.
The findings revealed that genetically higher DHEA-S levels are associated with increased blood pressure and a shorter lifespan among men. Interestingly, the same connection was not observed in women, suggesting a gender-specific effect.
DHEA-S is a precursor to male and female sex hormones, such as testosterone, which implies that elevated levels could influence health outcomes differently across genders. The study's results align with FDA warnings about testosterone therapy potentially increasing blood pressure in men. These insights raise important questions about the regulatory status and over-the-counter availability of DHEA supplements in the United States.
While the evidence on DHEA-S and lifespan has been limited, this study provides robust genetic data supporting its impact on men's health. Further research is needed to explore potential interventions and guideline considerations regarding DHEA supplementation.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Majority of Patients with Advanced Melanoma Remain Disease-Free Four Years Post-Neoadjuvant Immunotherapy
A groundbreaking study shows that nearly 87% of advanced melanoma patients remain disease-free four years after pre-surgical immunotherapy, highlighting the potential of neoadjuvant treatment to improve long-term outcomes.
Research Suggests Ozempic May Reduce Muscle Strength Despite Stable Muscle Size
Recent research indicates that Ozempic may cause muscle weakness even when muscle size remains unchanged, highlighting the importance of further clinical studies on its effects on muscle strength and health.
Advanced Neuropixels Probe Enables Large-Scale Neural Recording in Non-Human Primates
A new high-density Neuropixels probe enables comprehensive, brain-wide neural recordings in non-human primates, advancing neuroscience research on large animal brains.
Advancements in Cognitive Rehabilitation Show Faster Gains in Active Duty Military
New research reveals that strategic brain training protocols can accelerate cognitive recovery in active military personnel with brain injuries and PTSD, offering faster and more effective rehabilitation methods.